You're trying to compare Charlie Sheen to Emilio Estevez. GALE and CYTR were the bad brothers, RXII is the good brother. Matter of fact, RXII is the anti-pumper and actually needs to work on doing some kind of promotion to garner visibility.
This is the only company in bio (other than OTC) that I know of that doesn't do a CC following the ER. That and the low volume are the 2 things that might be keep me out this.
I'm cool with posting facts, regardless if they favor the longs or shorts, as long as it fact. The problem with a lot of pumpers is they are just as guilty as bashers. I don't care for either one.
Saying bashers don't bash bad stocks is saying the same thing as pumpers don't pump good stocks. Can't have one without the other!
FACT: Telling people to do their own DD is not bashing.
FACT: There are more paid pumpers than paid bashers on these boards.
FACT: I said this was a GOOD long term potential. (And that makes me a basher, how?)
FACT: You are a pumping clown and an ignorant one at that!
Do your own due diligence, learn how to read technicals on a chart and don't follow pumpers or bashers on message boards. Everyone has their own agenda to get you to buy or sell depending on THEIR position. However, pumpers far out number bashers. These message boards are a cess pool of the blind leading the blind.
As far as RXII, just look at the chart, low volume being manipulated, every pop gets knocked down, the company has a CEO that doesn't even have a quarterly conference call with shareholders and analysts (odd in and of itself).
Maybe this does go somewhere someday, but that day isn't today, it won't be tomorrow and it won't be next week. If you want in, it can be had at cheaper prices, just be patient. This isn't going anywhere until data is released and that won't be until the coming weeks. It's obvious that there isn't a mad rush to get in just yet as evidenced by volume.
Now, all you pumpers can click your little red thumbs down button to make yourselves feel better. But, the truth of my post is undeniable. I think RXII has some good LONG TERM potential, but I'll pass for now and so should you if you're considering getting in now. MM will keep knocking this down on 100 share trades. That's what happens on low volume, small float bio stocks.
Saw that myself. The run up to 2.869 on Tuesday was too much too soon for this stock and may have actually hurt it in the very near term. I don't see full retracement to 2.45 as the catalyst is too near term. Let's see if 2.59 support holds (which I think it will) and take it from there. I also don't see $3 before data, too much resistance in the higher 2's and too little volume to break through. RXII would need to be on the Baker Bros 13F when it gets filed today to break into the 3's.
To the contrary. It all depends on ones style of trading; some are straight day traders (in and out in 1 day), some are scalp traders, some are swing traders, some are momentum traders, some are short term investors and some are long term investors. Charts ALWAYS matter! Even if you're a long term investor, you have to take an entry at some point. It may not matter to you, but it matters to most if they buy in at 4 (overbought) or if they take a position at 2.50 (oversold). Saying charts are worthless is the most ignorant statement I've heard in years. It just goes to show you have no clue what you're talking about and have ZERO credibility.
Could've got it a few dollars cheaper, but I'm fine with that. I've been in other stocks, but have been keeping close tabs on ICPT. Once sell-side analyst Summer Street got bullish on ICPT and assigned a 650PT, I knew this would be a great stock. For SS to be bullish on anything is a great sign. They're usually right too.
Are you guys looking for anything specific in the CC?
Within 180 days of the date of filing of the PMA (§814.40), FDA will complete its review of the PMA and of the advisory committee`s report.